Navigation Links
Pharma News: CPhI South East Asia Opens Next Week in Jakarta, Indonesia
Date:3/16/2017

JAKARTA, Indonesia, March 16, 2017 /PRNewswire/ -- CPhI South East Asia returns to the Jakarta International Expo in Indonesia for its fifth edition during 22nd-24th March 2017 as the regional pharma companies expect robust growth. Sign up today!

A press conference was held on March 16th and saw the participation of Mr. Wiwy Sasongko -- General Manager Quintiles IMS Indonesia, Mr. Kendrariadi Suhanda -- Chairman of the Pharma Materials Management Club (PMMC) and Deputy secretary general at Indonesian Pharmaceutical Association (GP Farmasi), Mr. Teddy Iman Soewahjo -- Executive Director and Head of Packed Ingredients Division of PMMC, Mr. Vincent Harijanto -- Head of GP Farmasi's Research and Development of Raw Ingredients Trade and Industry and Vice Chairman of PMMC and Mr. Ivan Ferrari -- General Manager, PT UBM Pameran Niaga Indonesia.

Continue Reading
CPhI SEA Press Conference
CPhI SEA Press Conference

Several key topics, relevant to the region, were discussed. In fact, the slowing pace of global markets and the increasing threat of a new protectionist wave is transforming the outlook of South East Asian manufacturers which are now shifting their focus more on the actual prospects of regional exports. Mirroring this trend, international investors and companies are now pushing for more business in this regional market, across the entire ASEAN economy.

Comprising of 40% of the SEA economic output, Indonesia is the largest pharma market in the South East Asia Pacific region (SEA/AP). The country has the biggest and fastest growing economy in the SEA region and a pharma economy consisting of over 200 pharmaceutical companies. There are already 25-30 generic domestic companies with access to the international market, and equally, there are approximately 35 multinational companies established in the area.

These favourable macro trends are reflected at CPhI South East Asia where domestic manufacturers in particular are increasingly attending the event, with a view to opening up sales in international markets. As the biggest pharma event in the ASEAN region, CPhI South East Asia will gather over 5,500 attendees from 41 countries and more than 260 exhibitors (click here for the full list) to network, learn and do business for three days. Co-locating this year with Health Ingredients South East Asia, the event welcomes the best pharma ingredients professionals, packaging experts, machinery providers and contract manufacturing as well as nutraceutical companies from across the region.

The event's conference programme is a dedicated, content-enriched platform that will cover business outlook and markets, regulations and compliance, and manufacturing and supply chain. Sessions include "Strategies to improve market access", "Effective compliance strategies when managing 3rd parties" and "Big Data trends and applications in Supply Chain" and panel discussions on "A look at the pharmaceutical industry in South East Asia" and "ASEAN regulatory harmonization developments".

The event is supported by the national and regional governments and regional trade groups, such as: the Ministry of Health, Ministry of Industry, Indonesia Investment Coordinating Board, National Agency for Drug and Food Control.

Highlighted features at CPhI South East Asia in 2017 include:

  • The Investment Forum, matching key international players interested in investing in Indonesia with the top tier pharma companies in the country looking for reliable partners.
  • All distributors in the region have been invited to visit the event and network with peers and exhibitors through CPhI South East Asia's Distributor Network -- expanding its database of providers in the region with the aim of magnifying the reach throughout the whole ASEAN region.
  • The Business Matchmaking programme provides attendees with the opportunity to browse potential clients, schedule meetings before the event, and find new business partners.
  • Roadshows have been organized in many ASEAN countries to further promote CPhI South East Asia as a pharma bridge in the region.

For more information please visit: http://www.cphi.com/sea/         

About CPhI

CPhI brings together more than 100,000 pharmaceutical professionals each year. CPhI hosts events in Europe, Korea, China, India, Japan, Southeast Asia, Istanbul and Russia.

Ivan Ferrari
+62-21-2930-5959
ivan.ferrari@ubm.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pharma-news-cphi-south-east-asia-opens-next-week-in-jakarta-indonesia-300424834.html


'/>"/>
SOURCE CPhI SEA
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. RXi Pharmaceuticals to Webcast Fourth Quarter and Year End 2016 Financial Results on Thursday, March 30, 2017
2. Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Study Evaluating JZP-258 for the Treatment of Cataplexy and Excessive Daytime Sleepiness in Narcolepsy
3. Regen BioPharma Restructures Management Stock Compensation
4. Yisheng Biopharma to Present at BioPharma Asia Convention 2017 in Singapore
5. Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth
6. Healthcare Stocks on Investors Radar -- Delcath Systems, Palatin Technologies, AMAG Pharma, and IDEXX Laboratories
7. Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS)
8. Vanrx Pharmasystems comes to Interphex 2017 with growing momentum for its Aseptic Filling Workcells
9. PDL BioPharma to Present at the Oppenheimer 27th Annual Healthcare Conference
10. InDex Pharmaceuticals Gets Patent for Additional DIMS Compounds Granted in the US
11. AMO Pharma Enters into Collaboration Agreement with Ranedis Pharmaceuticals for Development of RND-001
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2019)... ... August 19, 2019 , ... ... centers, today announced the findings of research validating the clinical impact of MedAware’s ... were published 7 August 2019 in the Journal of American Medical Informatics ...
(Date:8/19/2019)... ... August 19, 2019 , ... ... to promote standards of excellence within the field of treatment for eating disorders, ... and communication with others who have a similar mission. , Founded in ...
(Date:8/16/2019)... ... August 16, 2019 , ... A new medical ... an alternative that both corrects the curve and maintains flexibility in the spine. ... techniques developed by medical staff of Shriners Hospitals for Children® — Philadelphia. It ...
Breaking Medicine Technology:
(Date:8/19/2019)... ... 2019 , ... Professional Enrollment Concepts (PEC), a top benefits ... have ranked #3056 on the 2019 Inc. 5000 Fastest-Growing Private Companies list. The ... most successful companies within the American economy's most dynamic segment—its independent small and ...
(Date:8/17/2019)... ... August 17, 2019 , ... Inc. ... Private Companies—the Inc. 5000 , For the 2nd Year In a Row, YellowTelescope ... of 192% Percent , Inc. magazine today revealed that YellowTelescope LLC (YellowTelescope, SEOversite, ...
(Date:8/16/2019)... ... August 16, 2019 , ... Tim Stouffer, ICS ... Mid-Atlantic and North East at the 2019 Safety Academy sponsored through Associated Builders ... existing construction safety concepts and define not only a safety program but focus ...
(Date:8/15/2019)... ... August 15, 2019 , ... Jon O'Brien, president of Catholics ... clinics to provide written assurance that they will comply with the Trump Administration’s ... Gag Rule, the new policy restricts providers and clinics that receive federal Title ...
(Date:8/14/2019)... ... August 15, 2019 , ... R3 Stem ... Mexico. R3 Stem Cell International is offering regenerative procedures with mesenchymal stem cells ... full procedure costs only $2950, which includes a complete IV therapy or two ...
Breaking Medicine News(10 mins):